HealthTree Logo
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Diffuse Large B Cell Lymphoma
  • Hodgkin Lymphoma
  • Stem Cell Transplant (Bone Marrow Transplant)
  • Lymphoma

About

Peter Riedell, MD, specializes in the care of adults with lymphomas and chronic lymphocytic leukemia. In particular, he has a special interest in the use of chimeric antigen receptor (CAR) T-cell therapy in the treatment of these conditions.

 

As a clinical researcher, Dr. Riedell serves as the principal investigator on several national and international clinical trials evaluating the role of targeted therapies, stem cell transplantation and cellular therapy in the treatment of lymphoma. He has been heavily involved in the development and implementation of therapies which harness a patient’s own immune system to fight cancer. His research aims to better characterize and enhance the safety and effectiveness of cellular therapy in order to improve patient outcomes.

Location

The University Of Chicago Medicine: 5841 S Maryland Ave, Chicago, IL 60637, USA

Get the latest thought leadership on Diffuse Large B Cell Lymphoma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Diffuse Large B Cell Lymphoma Newsletter" for Diffuse Large B Cell Lymphoma news, life with Diffuse Large B Cell Lymphoma stories, Diffuse Large B Cell Lymphoma clinical trials, Diffuse Large B Cell Lymphoma 101 articles and events with Diffuse Large B Cell Lymphoma experts.

Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:

Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram youtube